Short Life Agents in Balanced Anesthesia on Obstructive Sleep Apnea Syndrome
Summary
The investigators aim to assess the respiratory effect of short half-life agents in balanced anesthesia on patients suffering from non-treated or suspected obstructive sleep apnea syndrome (OSA) We will study the impact on OSA of a regimen of remifentanil-desflurane versus a regimen of fentanyl-sevoflurane. Each patient will undergo three respiratory portable polygraphies: the night before the surgery ; the first night following the surgery ; the third night following the surgery.
Timeline
- Start
- 2016-02
- Primary completion
- 2018-06
- Completion
- 2018-06
Outcome
Missed primary endpoint
paper were 20 (16-25) and 21 (16-26) events h-1 (P=0.82), respectively; corresponding values on the third postoperative night were 34 PMID 38862381 ↗
paper Use of spinal anaesthesia compared with general anaesthesia was not associated with a reduction in postoperative sleep apnoea severity PMID 38862381 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desflurane | Other / unclassified | — | — |
| Comparator | Fentanyl | Other / unclassified | — | — |
| Subject | Remifentanil | Small molecule | — | — |
| Comparator | Sevoflurane | Other / unclassified | — | — |